Evaluation and Initial Management of the Patient with Facial Skin Cancer

Facial Plastic Surgery Clinics of North America

Volumn 17, Issue 3, 2009, Pages 301-307

  Ho, Tang ^a   Byrne, Patrick J ^b  

^a UNIVERSITY OF TEXAS   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Basal cell carcinoma; Evaluation skin cancer; Management skin cancer; Melanoma; Nonmelanoma skin cancer; Skin cancer; Squamous cell carcinoma

Indexed keywords

ACETYLSALICYLIC ACID; FLUOROURACIL; IMIQUIMOD; ISOSULFAN BLUE; WARFARIN;

ACTINIC KERATOSIS; BASAL CELL CARCINOMA; BOWEN DISEASE; CANCER CLASSIFICATION; CANCER INVASION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CLINICAL TRIAL; CRYOSURGERY; CURETTAGE; FACE CANCER; HEAD AND NECK CANCER; HEALTH CARE COST; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MALIGNANT LENTIGO; MELANOMA; OVERALL SURVIVAL; PHOTODYNAMIC THERAPY; PHYSICAL EXAMINATION; REVIEW; SENTINEL LYMPH NODE BIOPSY; SKIN BIOPSY; SKIN CANCER; SQUAMOUS CELL CARCINOMA; SUN EXPOSURE; SURGICAL TECHNIQUE; SURVIVAL RATE; TREATMENT PLANNING; ULTRAVIOLET RADIATION;

ANTINEOPLASTIC AGENTS; BIOPSY, NEEDLE; CARCINOMA, BASAL CELL; CARCINOMA, SQUAMOUS CELL; CRYOSURGERY; DERMATOLOGIC AGENTS; FACIAL NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MELANOMA; MOHS SURGERY; NEOPLASM STAGING; PROGNOSIS; RADIOTHERAPY, ADJUVANT; RISK ASSESSMENT; SKIN NEOPLASMS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 68749098363     PISSN: 10647406     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fsc.2009.04.002     Document Type: Review

References (28)

1. Garbe C., and Leiter U. Melanoma epidemiology and trends. Clin Dermatol 27 1 (2009) 3-9
2. Lens M.B., and Dawes M. Global perspectives of contemporary epidemiological trends of cutaneous malignant melanoma. Br J Dermatol 150 2 (2004) 179-185
3. Christenson L.J., Borrowman T.A., Vachon C.M., et al. Incidence of basal cell and squamous cell carcinomas in a population younger than 40 years. JAMA 294 6 (2005) 681-690
4. Jemal A., Siegel R., Ward E., et al. Cancer statistics, 2008. CA Cancer J Clin 58 2 (2008) 71-96
5. Richmond-Sinclair N.M., Pandeya N., Ware R.S., et al. Incidence of basal cell carcinoma multiplicity and detailed anatomic distribution: longitudinal study of an Australian population. J Invest Dermatol 129 2 (2009) 323-328
6. Leiter U., and Garbe C. Epidemiology of melanoma and nonmelanoma skin cancer: the role of sunlight. Adv Exp Med Biol 624 (2008) 89-103
7. Strickland P.T., Vitasa B.C., West S.K., et al. Quantitative carcinogenesis in man: solar ultraviolet B dose dependence of skin cancer in Maryland watermen. J Natl Cancer Inst 81 24 (1989) 1910-1913
8. Gandini S., Sera F., Cattaruzza M.S., et al. Meta-analysis of risk factors for cutaneous melanoma. II. Sun exposure. Eur J Cancer 41 1 (2005) 45-60
9. Sabin S.R., Goldstein G., Rosenthal H.G., et al. Aggressive squamous cell carcinoma originating as a Marjolin's ulcer. Dermatol Surg 30 2 Pt 1 (2004) 229-230
10. Sexton M., Jones D.B., and Maloney M.E. Histologic pattern analysis of basal cell carcinoma: study of a series of 1039 consecutive neoplasms. J Am Acad Dermatol 23 6 Pt 1 (1990) 1118-1126
11. Brown C.I., and Perry A.E. Incidence of perineural invasion in histologically aggressive types of basal cell carcinoma. Am J Dermatopathol 22 2 (2000) 123-125
12. Nguyen T.H., and Ho D.Q. Nonmelanoma skin cancer. Curr Treat Options Oncol 3 3 (2002) 193-203
13. Rowe D.E., Carroll R.J., and Day Jr. C.L. Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip: implications for treatment modality selection. J Am Acad Dermatol 26 6 (1992) 976-990
14. Marks R. Squamous cell carcinoma. Lancet 347 9003 (1996) 735-738
15. Bath-Hextall F.J., Perkins W., Bong J., et al. Interventions for basal cell carcinoma of the skin. Cochrane Database Syst Rev 1 (2007) CD003412
16. Thomas D.J., King A.R., and Peat B.G. Excision margins for nonmelanotic skin cancer. Plast Reconstr Surg 112 1 (2003) 57-63
17. Rowe D.E., Carroll R.J., and Day Jr. C.L. Long-term recurrence rates in previously untreated (primary) basal cell carcinoma: implications for patient follow-up. J Dermatol Surg Oncol 15 3 (1989) 315-328
18. Locke J., Karimpour S., Young G., et al. Radiotherapy for epithelial skin cancer. Int J Radiat Oncol Biol Phys 51 3 (2001) 748-755
19. Schulte K.W., Lippold A., Auras C., et al. Soft x-ray therapy for cutaneous basal cell and squamous cell carcinomas. J Am Acad Dermatol 53 6 (2005) 993-1001
20. Kuflik E.G. Cryosurgery updated. J Am Acad Dermatol 31 6 (1994) 925-944
21. Geisse J., Caro I., Lindholm J., et al. Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from two phase III, randomized, vehicle-controlled studies. J Am Acad Dermatol 50 5 (2004) 722-733
22. Patel G.K., Goodwin R., Chawla M., et al. Imiquimod 5% cream monotherapy for cutaneous squamous cell carcinoma in situ (Bowen's disease): a randomized, double-blind, placebo-controlled trial. J Am Acad Dermatol 54 6 (2006) 1025-1032
23. Haigh P.I., DiFronzo L.A., and McCready D.R. Optimal excision margins for primary cutaneous melanoma: a systematic review and meta-analysis. Can J Surg 46 6 (2003) 419-426
24. Balch C.M., Soong S., Ross M.I., et al. Long-term results of a multi-institutional randomized trial comparing prognostic factors and surgical results for intermediate thickness melanomas (1.0 to 4.0 mm): Intergroup Melanoma Surgical Trial. Ann Surg Oncol 7 2 (2000) 87-97
25. Morton D.L., Thompson J.F., Cochran A.J., et al. Sentinel-node biopsy or nodal observation in melanoma. N Engl J Med 355 13 (2006) 1307-1317
26. Harwood A.R. Conventional fractionated radiotherapy for 51 patients with lentigo maligna and lentigo maligna melanoma. Int J Radiat Oncol Biol Phys 9 7 (1983) 1019-1021
27. Dawn M.E., Dawn A.G., and Miller S.J. Mohs surgery for the treatment of melanoma in situ: a review. Dermatol Surg 33 4 (2007) 395-402
28. Walling H.W., Scupham R.K., Bean A.K., et al. Staged excision versus Mohs micrographic surgery for lentigo maligna and lentigo maligna melanoma. J Am Acad Dermatol 57 4 (2007) 659-664